EMLETRA® Tablets
Brand Name: EMLETRA® Tablets
Composition: Lopinavir & Ritonavir Tablets IP
Manufacturer: Emcure®
Product Description
Medical Info
EMLETRA® is a prescription fixed-dose combination therapy consisting of two potent protease inhibitors: Lopinavir and Ritonavir. Manufactured by Emcure, these tablets are specifically indicated in combination with other antiretroviral agents for the treatment and management of human immunodeficiency virus (HIV-1) infection. Within this formulation, Lopinavir acts as the primary antiviral agent inhibiting viral replication, while Ritonavir functions as a pharmacokinetic enhancer, boosting Lopinavir levels to sustain therapeutic efficacy. Each standard bottle or package contains 60 tablets, offering a reliable, high-quality supply designed to support long-term clinical compliance and optimal patient outcomes.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
